Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Ying Liu
The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
75
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal Delns1-nCoV-RBD LAIV for COVID-19 in Healthy Adults
Number of pages: 32
Posted: 20 Jun 2022
Ricky Rui-Qi Zhang
,
Kwok-Hung Chan
,
Pui Wang
,
Runhong Zhou
,
Henry Kwong-Chi Yau
,
Creany Ka-Wai Wong
,
Meena Wai-Lam Au
,
Anthony Raymond Tam
,
Chi-Tao Ng
,
Matthew Kwok-Chung Lou
,
Na Liu
,
Haode Huang
,
Shaofeng Deng
,
Chun-Yee Tam
, Ying Liu,
Teng Long
,
Hoi-Wah Tsoi
,
Miko KW Ng
,
Jian-Piao Cai
,
Kelvin Kai-Wang To
,
Man-Fung Yuen
,
Zhiwei Chen
,
Honglin Chen
,
Kwok-Yung Yuen
and
Ivan Fan Ngai Hung
The University of Hong Kong - Li Ka Shing Faculty of Medicine, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - AIDS Institute, The University of Hong Kong - AIDS Institute, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Queen Mary Hospital, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases and The University of Hong Kong - School of Clinical Medicine
Downloads
75
(837,727)
View PDF
Download
Abstract:
Phase-1, intranasal, DelNS1-nCoV-RBD LAIV, COVID-19
Feedback